Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17668935 | 0.93 | OPRM1 (0.36) | DNM1 | |
| SCHEMBL17669045 | 0.91 | ZDHHC7 (0.37) | DNM1ALDH1A1 | |
| SCHEMBL2448728 | 0.85 | — | — | |
| SCHEMBL320980 | 0.85 | — | — | |
| SCHEMBL17669034 | 0.79 | DNM1 (0.32) | DNM1 | |
| SCHEMBL15015681 | 0.79 | ENPEP (0.31) | — | |
| SCHEMBL8470115 | 0.75 | DNM1 (0.42) | DNM1CA1CA2ALDH1A1TDP1 | |
| SCHEMBL319730 | 0.74 | — | — | |
| SCHEMBL2088586 | 0.73 | DNM1 (0.35) | DNM1CA1CA2ALDH1A1TDP1 | |
| SCHEMBL17669051 | 0.73 | OPRM1 (0.39) | DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3009439-B1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | SHINETSU CHEMICAL CO (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-9371341-B2 | Cyclic aminoorganoxysilane compound and its production method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-3009439-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-20160102111-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-04-14 | — | — | US | disclosed |
| EP-1922324-B1 | PROCESS FOR PRODUCING ORGANOALKOXYSILANES FROM ORGANIC ACIDS OR CYANATES AND HALOALKYLALKOXYSILNANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2013-07-17 | — | — | EP | disclosed |
| EP-1922324-A1 | PROCESS FOR PRODUCING ORGANOALKOXYSILANES FROM ORGANIC ACIDS OR CYANATES AND HALOALKYLALKOXYSILNANES | Momentive Performance Materials Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| US-7262312-B2 | Process for producing organoalkoxysilanes from organic acids or cyanates and haloalkylalkoxysilanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-08-28 | — | — | US | disclosed |
| WO-2007018997-A1 | PROCESS FOR PRODUCING ORGANOALKOXYSILANES FROM ORGANIC ACIDS OR CYANATES AND HALOALKYLALKOXYSILNANES | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070032673-A1 | PROCESS FOR PRODUCING ORGANOALKOXYSILANES FROM ORGANIC ACIDS OR CYANATES AND HALOALKYLALKOXYSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032673-A1 | PROCESS FOR PRODUCING ORGANOALKOXYSILANES FROM ORGANIC ACIDS OR CYANATES AND HALOALKYLALKOXYSILANES | OGA, ALKBH3, SLC43A1 | DNM1 4225/4885CA1 344/4885CA2 19/4885 |
| US-20160102111-A1 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND ITS PRODUCTION METHOD | BCAT2, BCAT1, AKR1B10 | DNM1 3942/4885CA1 948/4885CA2 2229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.